Priya Singhal - 22 Feb 2024 Form 4 Insider Report for BIOGEN INC. (BIIB)

Signature
/s/ Samuel Ntonme, attorney-in-fact for Priya Singhal
Issuer symbol
BIIB
Transactions as of
22 Feb 2024
Net transactions value
-$57,962
Form type
4
Filing time
26 Feb 2024, 19:54:07 UTC
Previous filing
21 Feb 2024
Next filing
03 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Sale $57,962 -262 -5.1% $221.23 4,886 22 Feb 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).